- Home
- PETZ vs IMNN Comparison
PETZ vs IMNN Comparison
Compare PETZ & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETZ
- IMNN
- Stock Information
- Founded
- PETZ 2002
- IMNN 1982
- Country
- PETZ China
- IMNN United States
- Employees
- PETZ N/A
- IMNN N/A
- Industry
- PETZ Steel/Iron Ore
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- PETZ Industrials
- IMNN Health Care
- Exchange
- PETZ Nasdaq
- IMNN Nasdaq
- Market Cap
- PETZ 13.1M
- IMNN 15.1M
- IPO Year
- PETZ 2017
- IMNN 1985
- Fundamental
- Price
- PETZ $1.16
- IMNN $1.09
- Analyst Decision
- PETZ
- IMNN Strong Buy
- Analyst Count
- PETZ 0
- IMNN 1
- Target Price
- PETZ N/A
- IMNN $14.00
- AVG Volume (30 Days)
- PETZ 9.7K
- IMNN 579.7K
- Earning Date
- PETZ 10-29-2024
- IMNN 08-14-2024
- Dividend Yield
- PETZ N/A
- IMNN N/A
- EPS Growth
- PETZ N/A
- IMNN N/A
- EPS
- PETZ N/A
- IMNN N/A
- Revenue
- PETZ $3,175,809.00
- IMNN N/A
- Revenue This Year
- PETZ N/A
- IMNN N/A
- Revenue Next Year
- PETZ N/A
- IMNN N/A
- P/E Ratio
- PETZ N/A
- IMNN N/A
- Revenue Growth
- PETZ 2.49
- IMNN N/A
- 52 Week Low
- PETZ $0.89
- IMNN $0.48
- 52 Week High
- PETZ $1.74
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- PETZ 45.74
- IMNN 44.84
- Support Level
- PETZ $1.10
- IMNN $1.03
- Resistance Level
- PETZ $1.21
- IMNN $1.15
- Average True Range (ATR)
- PETZ 0.06
- IMNN 0.07
- MACD
- PETZ -0.00
- IMNN -0.00
- Stochastic Oscillator
- PETZ 31.58
- IMNN 22.58
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling of petfood and restaurant operations. The company has two operating segments which include Petfood sales and Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.